Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

PURPOSE: The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive full doses of anthracyclines. The purpose of this study was to evaluate the effect of DID on the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Res Treat
Hoofdauteurs: Ha, Hyerim, Keam, Bhumsuk, Kim, Tae Min, Jeon, Yoon Kyung, Lee, Se-Hoon, Kim, Dong-Wan, Kim, Chul Woo, Heo, Dae Seog
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Korean Cancer Association 2016
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720063/
https://ncbi.nlm.nih.gov/pubmed/25865654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.339
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items